These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32171470)

  • 1. Androgenic effects on ventricular repolarization: A translational study from the international pharmacovigilance database to iPSC-cardiomyocytes.
    Salem JE; Yang T; Moslehi JJ; Waintraub X; Gandjbakhch E; Bachelot A; Hidden-Lucet F; Hulot JS; Knollmann BC; Lebrun-Vignes B; Funck-Brentano C; Glazer AM; Roden DM
    Ann Endocrinol (Paris); 2021 Jun; 82(3-4):132-133. PubMed ID: 32171470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgenic Effects on Ventricular Repolarization: A Translational Study From the International Pharmacovigilance Database to iPSC-Cardiomyocytes.
    Salem JE; Yang T; Moslehi JJ; Waintraub X; Gandjbakhch E; Bachelot A; Hidden-Lucet F; Hulot JS; Knollmann BC; Lebrun-Vignes B; Funck-Brentano C; Glazer AM; Roden DM
    Circulation; 2019 Sep; 140(13):1070-1080. PubMed ID: 31378084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study.
    Salem JE; Bretagne M; Lebrun-Vignes B; Waintraub X; Gandjbakhch E; Hidden-Lucet F; Gougis P; Bachelot A; Funck-Brentano C;
    Arch Cardiovasc Dis; 2019 Nov; 112(11):699-712. PubMed ID: 31477476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
    Lu HR; Yan GX; Gallacher DJ
    J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex-Related Differences in Drug-Induced QT Prolongation and Torsades de Pointes: A New Model System with Human iPSC-CMs.
    Huo J; Wei F; Cai C; Lyn-Cook B; Pang L
    Toxicol Sci; 2019 Feb; 167(2):360-374. PubMed ID: 30247688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QT interval prolongation: prevalence, risk factors and pharmacovigilance data among methadone-treated patients in France.
    Perrin-Terrin A; Pathak A; Lapeyre-Mestre M
    Fundam Clin Pharmacol; 2011 Aug; 25(4):503-10. PubMed ID: 20825488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does terfenadine-induced ventricular tachycardia/fibrillation directly relate to its QT prolongation and Torsades de Pointes?
    Lu HR; Hermans AN; Gallacher DJ
    Br J Pharmacol; 2012 Jun; 166(4):1490-502. PubMed ID: 22300168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex differences in ventricular repolarization: from cardiac electrophysiology to Torsades de Pointes.
    Abi-Gerges N; Philp K; Pollard C; Wakefield I; Hammond TG; Valentin JP
    Fundam Clin Pharmacol; 2004 Apr; 18(2):139-51. PubMed ID: 15066127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Availability of human induced pluripotent stem cell-derived cardiomyocytes in assessment of drug potential for QT prolongation.
    Nozaki Y; Honda Y; Tsujimoto S; Watanabe H; Kunimatsu T; Funabashi H
    Toxicol Appl Pharmacol; 2014 Jul; 278(1):72-7. PubMed ID: 24742750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antiemetics and cardiac effects potentially linked to prolongation of the QT interval: Case/non-case analysis in the national pharmacovigilance database].
    Rochoy M; Auffret M; Béné J; Gautier S;
    Rev Epidemiol Sante Publique; 2017 Feb; 65(1):1-8. PubMed ID: 27988172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticancer drug-induced life-threatening ventricular arrhythmias: a World Health Organization pharmacovigilance study.
    Salem JE; Nguyen LS; Moslehi JJ; Ederhy S; Lebrun-Vignes B; Roden DM; Funck-Brentano C; Gougis P
    Eur Heart J; 2021 Oct; 42(38):3915-3928. PubMed ID: 34370839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological Characteristics of Human iPSC-Derived Cardiomyocytes for the Assessment of Drug-Induced Proarrhythmic Potential.
    Yamamoto W; Asakura K; Ando H; Taniguchi T; Ojima A; Uda T; Osada T; Hayashi S; Kasai C; Miyamoto N; Tashibu H; Yoshinaga T; Yamazaki D; Sugiyama A; Kanda Y; Sawada K; Sekino Y
    PLoS One; 2016; 11(12):e0167348. PubMed ID: 27923051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen Deprivation Therapy for Prostatic Cancer in Patients With Torsades de Pointes.
    Lazzerini PE; Bertolozzi I; Acampa M; Cantara S; Castagna MG; Pieragnoli L; D'Errico A; Rossi M; Bisogno S; El-Sherif N; Boutjdir M; Laghi-Pasini F; Capecchi PL
    Front Pharmacol; 2020; 11():684. PubMed ID: 32477142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Torsades de pointes and QT prolongation Associations with Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System.
    Teng C; Walter EA; Gaspar DKS; Obodozie-Ofoegbu OO; Frei CR
    Int J Med Sci; 2019; 16(7):1018-1022. PubMed ID: 31341415
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiarrhythmic properties of a rapid delayed-rectifier current activator in rabbit models of acquired long QT syndrome.
    Diness TG; Yeh YH; Qi XY; Chartier D; Tsuji Y; Hansen RS; Olesen SP; Grunnet M; Nattel S
    Cardiovasc Res; 2008 Jul; 79(1):61-9. PubMed ID: 18367457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case ascertainment and estimated incidence of drug-induced long-QT syndrome: study in Southwest France.
    Molokhia M; Pathak A; Lapeyre-Mestre M; Caturla L; Montastruc JL; ; McKeigue P
    Br J Clin Pharmacol; 2008 Sep; 66(3):386-95. PubMed ID: 18637888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular and ionic mechanisms underlying erythromycin-induced long QT intervals and torsade de pointes.
    Antzelevitch C; Sun ZQ; Zhang ZQ; Yan GX
    J Am Coll Cardiol; 1996 Dec; 28(7):1836-48. PubMed ID: 8962574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotic-related QTc prolongation, torsade de pointes and sudden death.
    Haddad PM; Anderson IM
    Drugs; 2002; 62(11):1649-71. PubMed ID: 12109926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced torsades de pointes: a review of the Swedish pharmacovigilance database.
    Aström-Lilja C; Odeberg JM; Ekman E; Hägg S
    Pharmacoepidemiol Drug Saf; 2008 Jun; 17(6):587-92. PubMed ID: 18449951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced QT Interval Prolongation in the Intensive Care Unit.
    Etchegoyen CV; Keller GA; Mrad S; Cheng S; Di Girolamo G
    Curr Clin Pharmacol; 2017; 12(4):210-222. PubMed ID: 29473523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.